IsoRay Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)

Form 8-K/A date of report 01-08-24 true 0000728387 0000728387 2024-01-08 2024-01-08

 

 

 

 

 

 

 

 

 

 

 

Registrant’s telephone number, including area code: (206) 676-0900

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

As previously reported by Perspective Therapeutics, Inc. (the “Company”) on a Current Report on Form 8-K filed with the Securities and Exchange Commission on January 11, 2024 (the “Initial Form 8-K”), the Company entered into that certain (i) Investment Agreement (the “Investment Agreement”), dated January 8, 2024, with Lantheus Alpha Therapy, LLC, a Delaware limited liability company (“Lantheus”), (ii) Asset Purchase Agreement (the “Asset Purchase Agreement”), dated January 8, 2024, with Progenics Pharmaceuticals, Inc., a Delaware corporation, and (iii) Option Agreement (the “Option Agreement” and together with the Investment Agreement and the Asset Purchase Agreement, the “Agreements”), dated January 8, 2024, with Lantheus.

 

This Current Report on Form 8-K/A (“Amendment No. 1”) is being filed as an amendment to the Initial Form 8-K to file, as exhibits under Item 9.01(d), copies of the Investment Agreement, Asset Purchase Agreement and Option Agreement, which are attached hereto as Exhibits 10.1, 10.2 and 10.3, respectively. This Amendment No. 1 supplements the Initial Form 8-K and should be read in conjunction with the Initial Form 8-K.

 

Item 9.01.          Financial Statements and Exhibits.

 

(d)         Exhibits

 

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.